|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | |
| G16B 15/00 | |||
| G01N 23/20 | |||
| A61K 31/454 | |||
| A61K 31/517 | |||
| C12Q 1/37 | |||
| A61P 35/00 | |||
| A61P 43/00 |
| (11) | Number of the document | 3160486 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15811480.1 |
| Date of filing the European patent application | 2015-06-26 | |
| (97) | Date of publication of the European application | 2017-05-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/037980 |
| Date | 2015-06-26 |
| (87) | Number | WO 2015/200795 |
| Date | 2015-12-30 |
| (30) | Number | Date | Country code |
| 201462018445 P | 2014-06-27 | US |
| (72) |
CHAMBERLAIN, Philip Paul, US
CATHERS, Brian, E., US
LOPEZ-GIRONA, Antonia, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | COMPOSITIONS AND METHODS FOR INDUCING CONFORMATIONAL CHANGES IN CEREBLON OTHER E3 UBIQUITIN LIGASES |
| COMPOSITIONS AND METHODS FOR INDUCING CONFORMATIONAL CHANGES IN CEREBLON OTHER E3 UBIQUITIN LIGASES |